These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20941995)

  • 1. [Antibody-dependent cell-mediated cytotoxicity (ADCC)].
    Mukaida N
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():33-5. PubMed ID: 20941995
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic tests: Antibody-dependent cell-mediated cytotoxicity (ADCC)].
    Mukaida N
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():34-6. PubMed ID: 16111182
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in multiple myeloma.
    Matsuzaki H; Kagimoto T; Oda T; Kawano F; Takatsuki K
    Jpn J Clin Oncol; 1985 Dec; 15(4):611-7. PubMed ID: 4094094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.
    Poston RN; Morgan RS
    Immunology; 1983 Nov; 50(3):461-9. PubMed ID: 6629417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibody-dependent cell-mediated cytotoxicity].
    Mukaida N
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():193-5. PubMed ID: 9097587
    [No Abstract]   [Full Text] [Related]  

  • 6. Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cells.
    Perussia B; Loza MJ
    Methods Mol Biol; 2000; 121():179-92. PubMed ID: 10818726
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
    Komatsu F; Tamiya H
    Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R; Hatanaka S; Shoji-Hosaka E; Sakurada M; Kobayashi Y; Uehara A; Yokoi H; Nakamura K; Shitara K
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
    Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.
    de Landazuri MO; Silva A; Alvarez J; Herberman RB
    J Immunol; 1979 Jul; 123(1):252-8. PubMed ID: 376742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
    Weinhold KJ; Bolognesi DP; Matthews TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human IgG1 and mouse IgG3 but not monomeric IgM or IgE facilitate antibody-dependent cell-mediated cytotoxicity by human natural killer cells.
    Shenoy AM; Brahmi Z
    Nat Immun Cell Growth Regul; 1989; 8(6):338-48. PubMed ID: 2622463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1.
    Hildreth JE; Hampton R; Halsey NA
    Clin Immunol; 1999 Feb; 90(2):203-12. PubMed ID: 10080832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
    Fuson EW; Cole AJ; Hubbard RA
    J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.